Imago Pharmaceuticals™ is in no way affiliated with Imago Biosciences™. All Rights Reserved.

IGP002

Development Candidate Nominated

Parkinson's Disease (PD) Idiopathic Pulmonary Fibrosis (IPF) Spinal Muscular Atrophy (SMA) Alzheimer's Disease (AD)

Imago Pipeline

JNK Program

In the News

CureSMA Award to study role of JNK in SMA